Herbas VPB

Print
EN | LT
LT - Nauji junginiai
EN - NOVEL COMPOUNDS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/04 (2006.01)
A61K 31/4427 (2006.01)
A61K 31/4523 (2006.01)
A61K 31/497 (2006.01)
A61K 31/501 (2006.01)
A61K 31/506 (2006.01)
A61P 31/06 (2006.01)
European patent
(11) Number of the document 3668853
(13) Kind of document T
(96) European patent application number 18752172.9
Date of filing the European patent application 2018-08-15
(97) Date of publication of the European application 2020-06-24
(45) Date of publication and mention of the grant of the patent 2021-09-29
(46) Date of publication of the claims translation 2022-03-10
PCT application
(86) Number PCT/EP2018/072144
Date 2018-08-15
PCT application publication
(87) Number WO 2019/034701
Date 2019-02-21
Priority applications
(30) Number Date Country code
17382570 2017-08-16 EP
Inventors
(72)
PORRAS DE FRANCISCO, Esther , ES
REMUIÑAN-BLANCO, Modesto Jesús , ES
BOUROTTE, Marilyne , FR
DEPREZ, Benoit , FR
WILLAND, Nicolas , FR
Grantee
(73) GlaxoSmithKline Intellectual Property Development Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, GB
Bioversys AG , Technologiepark Basel Hochbergerstrasse 60c, 4057 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Nauji junginiai
  NOVEL COMPOUNDS
Last renewal fee
Payment date Validity (years) Amount
2025-07-23 8 185.00 EUR
Next renewal fee
2026-08-15